174 related articles for article (PubMed ID: 21557805)
1. The unmet need of patients with atrial fibrillation: AVERROES and the novel oral anticoagulants.
Hart RG
Int J Stroke; 2011 Jun; 6(3):207-8. PubMed ID: 21557805
[No Abstract] [Full Text] [Related]
2. Clopidogrel plus aspirin vs oral anticoagulation for atrial fibrillation: the ACTIVE W trial.
DeSilvey DL
Am J Geriatr Cardiol; 2006; 15(5):326-7. PubMed ID: 16957455
[No Abstract] [Full Text] [Related]
3. Atrial fibrillation, is warfarin the only option for stroke prevention?
Khan M; Kamal AK
J Pak Med Assoc; 2011 Mar; 61(3):301-2. PubMed ID: 21465955
[No Abstract] [Full Text] [Related]
4. [Anticoagulation in atrial fibrillation. ACTIVE Study (Arterial fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events)].
Meinertz T
Internist (Berl); 2007 Aug; 48(8):874-5. PubMed ID: 17628764
[No Abstract] [Full Text] [Related]
5. Apixaban for the prevention of stroke in atrial fibrillation.
Littrell R; Flaker G
Expert Rev Cardiovasc Ther; 2012 Feb; 10(2):143-9. PubMed ID: 22292869
[TBL] [Abstract][Full Text] [Related]
6. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial.
; Connolly S; Pogue J; Hart R; Pfeffer M; Hohnloser S; Chrolavicius S; Pfeffer M; Hohnloser S; Yusuf S
Lancet; 2006 Jun; 367(9526):1903-12. PubMed ID: 16765759
[TBL] [Abstract][Full Text] [Related]
7. Atrial fibrillation, is warfarin the only option for stroke prevention?
Khan M; Kamal AK
J Pak Med Assoc; 2011 Apr; 61(4):406-7. PubMed ID: 21465988
[No Abstract] [Full Text] [Related]
8. Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events.
; ; Connolly S; Yusuf S; Budaj A; Camm J; Chrolavicius S; Commerford PJ; Flather M; Fox KA; Hart R; Hohnloser S; Joyner C; Pfeffer M; Anand I; Arthur H; Avezum A; Bethala-Sithya M; Blumenthal M; Ceremuzynski L; De Caterina R; Diaz R; Flaker G; Frangin G; Franzosi MG; Gaudin C; Golitsyn S; Goldhaber S; Granger C; Halon D; Hermosillo A; Hunt D; Jansky P; Karatzas N; Keltai M; Lanas F; Lau CP; Le Heuzey JY; Lewis BS; Morais J; Morillo C; Oto A; Paolasso E; Peters RJ; Pfisterer M; Piegas L; Pipillis T; Proste C; Sitkei E; Swedberg K; Synhorst D; Talajic M; Trégou V; Valentin V; van Mieghem W; Weintraub W; Varigos J
Am Heart J; 2006 Jun; 151(6):1187-93. PubMed ID: 16781218
[TBL] [Abstract][Full Text] [Related]
9. Underutilisation of Guideline-based Therapy Primary Prevention among Patients Presenting with AF-related Ischaemic Stroke.
Fabiaña N; Ramaswami AP; Ang ES; De Silva DA
Ann Acad Med Singap; 2015 Jul; 44(7):266-8. PubMed ID: 26377061
[No Abstract] [Full Text] [Related]
10. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
[TBL] [Abstract][Full Text] [Related]
11. [The AVERROES study].
De Caterina R; Abbate R
G Ital Cardiol (Rome); 2011 Sep; 12(9):551-5. PubMed ID: 21892215
[No Abstract] [Full Text] [Related]
12. Prevention of stroke in patients with atrial fibrillation.
Med Lett Drugs Ther; 2009 Jun; 51(1313):41. PubMed ID: 19478692
[No Abstract] [Full Text] [Related]
13. A new era of antithrombotic therapy in patients with atrial fibrillation.
Golwala H; Dib C; Tafur A; Abu-Fadel MS
Am J Med Sci; 2012 Aug; 344(2):128-35. PubMed ID: 22245946
[TBL] [Abstract][Full Text] [Related]
14. Is Apixaban (Eliquis) the "ideal" anticoagulant to replace warfarin for stroke prevention in atrial fibrillation?
Strain J; Templeton K
S D Med; 2013 Jan; 66(1):20-1. PubMed ID: 23342716
[No Abstract] [Full Text] [Related]
15. Clinical and Economic Implications of Apixaban Versus Aspirin in the Low-Risk Nonvalvular Atrial Fibrillation Patients.
Lip GY; Lanitis T; Mardekian J; Kongnakorn T; Phatak H; Dorian P
Stroke; 2015 Oct; 46(10):2830-7. PubMed ID: 26316345
[TBL] [Abstract][Full Text] [Related]
16. Apixaban in patients with atrial fibrillation.
Lynch DR
N Engl J Med; 2011 Jun; 364(24):2362-3; author reply 2363-4. PubMed ID: 21675902
[No Abstract] [Full Text] [Related]
17. Oral factor Xa inhibitors for the prevention of stroke in atrial fibrillation.
Piccini JP; Lopes RD; Mahaffey KW
Curr Opin Cardiol; 2010 Jul; 25(4):312-20. PubMed ID: 20520539
[TBL] [Abstract][Full Text] [Related]
18. New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint.
Rubboli A; Agewall S; Huber K; Lip GY
Int J Cardiol; 2015 Oct; 196():133-8. PubMed ID: 26093527
[TBL] [Abstract][Full Text] [Related]
19. Novel oral anticoagulants in secondary prevention of stroke.
Diener HC; Easton JD; Hankey GJ; Hart RG
Best Pract Res Clin Haematol; 2013 Jun; 26(2):131-9. PubMed ID: 23953901
[TBL] [Abstract][Full Text] [Related]
20. [Current and future therapies for prophylaxis of thromboembolism in atrial fibrillation].
Geisler T; Gawaz M
MMW Fortschr Med; 2011 Apr; 153(15):27-30; quiz 31. PubMed ID: 21667556
[No Abstract] [Full Text] [Related]
[Next] [New Search]
